The Institute of Translational Health Sciences (ITHS) Translational Research Unit (TRU), located at the University of Washington Medical Center, offers investigators the comprehensive support and infrastructure needed to conduct clinical and translational research. Equipped with cutting-edge technology, the TRU fosters a dynamic environment where research and clinical practice are tightly integrated, benefiting both patients and healthcare providers by advancing the science of medicine and improving patient care outcomes.
In October of 2022, Nora Disis, M.D., a University of Washington oncology professer, former ITHS Principal Investigator, and Director of the Cancer Vaccine Institute, authored a study reporting that an experimental vaccine against breast cancer safely generated a strong immune response to a key tumor protein. The findings suggested the vaccine may be able to treat different types of breast cancer…
Read the full article here.
